5-bromo-2-methylpyridine-3-carboxylic acid;cyclopropylmethanamine;N-(cyclopropylmethyl)-2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxamide;2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxylic acid;2-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]pyrimidin-4-amine
C65H73BBrN17O7 — CID 158814982
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-bromo-2-methylpyridine-3-carboxylic acid;cyclopropylmethanamine;N-(cyclopropylmethyl)-2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxamide;2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxylic acid;2-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]pyrimidin-4-amine
5-bromo-2-methylpyridine-3-carboxylic acid;cyclopropylmethanamine;N-(cyclopropylmethyl)-2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxamide;2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxylic acid;2-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]pyrimidin-4-amine (PubChem CID 158814982) has the molecular formula C65H73BBrN17O7 and a molecular weight of 1295.13 g/mol. Its IUPAC name is 5-bromo-2-methylpyridine-3-carboxylic acid;cyclopropylmethanamine;N-(cyclopropylmethyl)-2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxamide;2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxylic acid;2-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]pyrimidin-4-amine.
Molecular Properties
| Compound Name | 5-bromo-2-methylpyridine-3-carboxylic acid;cyclopropylmethanamine;N-(cyclopropylmethyl)-2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxamide;2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxylic acid;2-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]pyrimidin-4-amine |
|---|---|
| PubChem CID | 158814982 |
| Molecular Formula | C65H73BBrN17O7 |
| Molecular Weight | 1295.13 g/mol |
| Exact Mass | 1293.52 |
| IUPAC Name | 5-bromo-2-methylpyridine-3-carboxylic acid;cyclopropylmethanamine;N-(cyclopropylmethyl)-2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxamide;2-methyl-5-[2-[(2-methylpyrimidin-4-yl)amino]-4-pyridinyl]pyridine-3-carboxylic acid;2-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]pyrimidin-4-amine |
| SMILES | Cc1ncc(Br)cc1C(=O)O.Cc1nccc(Nc2cc(-c3cnc(C)c(C(=O)NCC4CC4)c3)ccn2)n1.Cc1nccc(Nc2cc(-c3cnc(C)c(C(=O)O)c3)ccn2)n1.Cc1nccc(Nc2cc(B3OC(C)(C)C(C)(C)O3)ccn2)n1.NCC1CC1 |
| InChI | InChI=1S/C21H22N6O.C17H15N5O2.C16H21BN4O2.C7H6BrNO2.C4H9N/c1-13-18(21(28)25-11-15-3-4-15)9-17(12-24-13)16-5-7-23-20(10-16)27-19-6-8-22-14(2)26-19;1-10-14(17(23)24)7-13(9-20-10)12-3-5-19-16(8-12)22-15-4-6-18-11(2)21-15;1-11-18-9-7-13(20-11)21-14-10-12(6-8-19-14)17-22-15(2,3)16(4,5)23-17;1-4-6(7(10)11)2-5(8)3-9-4;5-3-4-1-2-4/h5-10,12,15H,3-4,11H2,1-2H3,(H,25,28)(H,22,23,26,27);3-9H,1-2H3,(H,23,24)(H,18,19,21,22);6-10H,1-5H3,(H,18,19,20,21);2-3H,1H3,(H,10,11);4H,1-3,5H2 |
| InChIKey | IVDQAUGQWPRQNO-UHFFFAOYSA-N |
| XLogP | 10.85 |
| TPSA | 338.95 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 91 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1295.13 |
| LogP ≤ 5 | 10.85 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 21 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158814982 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.